Undisclosed Infectious Disease Vaccine(s)

About Ziphius Vaccines

Ziphius Vaccines is an emerging biotech developing a proprietary self-amplifying RNA (saRNA) platform coupled with in-house lipid nanoparticle (LNP) delivery systems. The company leverages this technology to create a pipeline targeting infectious diseases, rare diseases, and oncology, aiming for potent, durable effects at lower doses than conventional mRNA. As a private, pre-clinical stage company, Ziphius is building its scientific team and platform capabilities to position itself in the competitive next-generation RNA therapeutics space.

Therapeutic Areas